Answers are grounded in this paper and cite their sources.
Regular use of aspirin after diagnosis was associated with longer survival among patients with mutated-PIK3CA colorectal cancer, but not among patients with wild-type PIK3CA cancer. The findings from this molecular pathological epidemiology study suggest that the PIK3CA mutation in colorectal cancer may serve as a predictive molecular biomarker for adjuvant aspirin therapy. (Funded by The National Institutes of Health and others.).
No takes yet. Share an insight, caveat, or question.
Liao et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: